Guest guest Posted September 14, 2002 Report Share Posted September 14, 2002 Insider speaks out against the FDA Alosetron (Lotronex)a drug for irritable bowel syndromewas withdrawn from sale in the United States in late 2000 after reports of serious adverse events, but six weeks later the special joint advisory committee to the United States Food and Drug Administration (FDA) recommended its remarketing. A senior advisor from the committee has warned of more deaths if the drug is relaunched, and a former insider of the FDA says that the agency has become a servant of the pharmaceutical industry. On p 592 Moynihan charts the path of the drug and examines the truth or otherwise of inappropriate corporate influence in drug licensing. (Credit: MARTY KATZ) ---------- ---- Home Help Search/Archive Feedback Table of Contents --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.385 / Virus Database: 217 - Release 9/4/02 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.